Evidence boundary
There is no validated glutathione headache rate or countdown
Compounded glutathione injections used in wellness care are not FDA-approved finished drug products with a prescribing label that defines headache incidence, timing, severity, or duration. Published oral glutathione studies have focused mainly on blood or tissue glutathione and oxidative-stress markers; they do not establish an injection-specific headache rate. A small oral study, a clinic side-effect list, or a testimonial also cannot predict whether an individual headache is mild, medication-related, or a sign of another condition.
- Do not convert “commonly reported online” into a percentage or promise that a headache should resolve within a fixed number of hours.
- A symptom after use creates a useful timeline, but it does not separate glutathione from another infusion ingredient, dehydration, low food intake, migraine, infection, blood-pressure change, medication effect, or another cause.
- Route matters: an oral capsule, patient-specific compounded injection, and multi-ingredient IV infusion do not have interchangeable absorption, quality, or adverse-event evidence.